Prosecution Insights
Last updated: May 29, 2026

Janssen Research & Development LLC

4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready

Portfolio Summary

4
Total Pending OAs
4
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (25%)
2
Medium (50%)
0
Easy (0%)
1
Unknown (25%)

Rejection Statute Mix

BucketCases
§101 only1 (25%)
§103 only2 (50%)
No statute on record1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
25% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
75% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
VAN DUZER, ALEXIS KIM 1 60.0% +66.7%
POLLOCK, ZACHARY JOSEPH 1 26.1% +59.2%
TCHERKASSKAYA, OLGA V 1 55.4% +46.6%
MPAMUGO, CHINYERE 1 26.6% +26.9%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18706576 LIGHT-BASED VISUAL CUEING OF MEDICATION DELIVERY INSTRUCTIONS USING LIGHT AND MOTION SENSORS POLLOCK, ZACHARY JOSEPH 43d overdue
18689855 Selecting Clinical Trial Sites Based on Multiple Target Variables Using Machine Learning MPAMUGO, CHINYERE 34d

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18752571 PLATFORM FOR MANAGING CONTEXTUAL AVAILABILITY OF ELECTRONIC HEALTH DATA VAN DUZER, ALEXIS KIM 60d overdue
18706576 LIGHT-BASED VISUAL CUEING OF MEDICATION DELIVERY INSTRUCTIONS USING LIGHT AND MOTION SENSORS POLLOCK, ZACHARY JOSEPH 43d overdue
18694042 HIGH-DOSE COMPRESSIBLE DOSAGE FORMS MANUFACTURED BY SIMULTANEOUS MELT-COATING AND MELT-GRANULATION OF ACTIVE PHARMACEUTICAL INGREDIENTS TCHERKASSKAYA, OLGA V 3d overdue
18689855 Selecting Clinical Trial Sites Based on Multiple Target Variables Using Machine Learning MPAMUGO, CHINYERE 34d

Top Art Units

Art UnitApps
3681 1
3715 1
1615 1
3685 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18752571 PLATFORM FOR MANAGING CONTEXTUAL AVAILABILITY OF ELECTRONIC HEALTH DATA VAN DUZER, ALEXIS KIM 3681 §103 Non-Final OA 60d overdue Pending Jun 24, 2024
18706576 LIGHT-BASED VISUAL CUEING OF MEDICATION DELIVERY INSTRUCTIONS USING LIGHT AND MOTION SENSORS POLLOCK, ZACHARY JOSEPH 3715 §103 Non-Final OA 43d overdue Pending May 01, 2024
18694042 HIGH-DOSE COMPRESSIBLE DOSAGE FORMS MANUFACTURED BY SIMULTANEOUS MELT-COATING AND MELT-GRANULATION OF ACTIVE PHARMACEUTICAL INGREDIENTS TCHERKASSKAYA, OLGA V 1615 Other Non-Final OA 3d overdue Pending Mar 21, 2024
18689855 Selecting Clinical Trial Sites Based on Multiple Target Variables Using Machine Learning MPAMUGO, CHINYERE 3685 §101 Non-Final OA 34d Pending Mar 06, 2024

Managing Janssen Research & Development LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month